Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Fate Therapeutics divulges novel Wnt compositions

Aug. 8, 2012

Dyax presents new plasma kallikrein-binding antibodies

Aug. 7, 2012

Research at Bioenergenix yields novel PAS-kinase inhibitors

Aug. 7, 2012

Novel protein kinase inhibitors disclosed

Aug. 7, 2012

New antibiotics prepared in Portugal

Aug. 7, 2012

Scientists develop new DGAT inhibitors

Aug. 7, 2012

Novel fatty acid synthase inhibitors designed

Aug. 7, 2012

Beta Pharma patents novel protein kinase inhibitors

Aug. 6, 2012

Belgian scientists divulge novel antiviral alphabodies

Aug. 6, 2012

Bionor Pharma presents new candidate vaccines

Aug. 6, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...